Improvement in sinonasal quality‐of‐life indicators for pediatric patients with cystic fibrosis treated with elexacaftor‐tezacaftor‐ivacaftor
Carlos X. Castellanos, Beth Osterbauer, Steven J. Hasday, Thomas G. Keens, Jeffrey A. Koempel, Elisabeth H. Ference
Topics & Concepts
IvacaftorMedicineCystic fibrosisQuality of life (healthcare)Intensive care medicineInternal medicineCystic fibrosis transmembrane conductance regulatorNursingSinusitis and nasal conditionsCystic Fibrosis Research AdvancesAllergic Rhinitis and Sensitization